Poster SESSIONS
63
Poster, 24 June 2014
Authors are asked to present their posters during the poster sessions.
P-25-014
The improvement of social functioning in
schizophrenic patients treated with paliperi-
done extended-release: 12-month observa-
tional surveillance in real clinical practice
with 1405 patients
Akihide Wakamatsu, Tokyo, Japan
A. Tanimura, K. Morita, T. Ohnishi, K. Toori-
yama, T. Yamaoka, H. Usui, Y. Ogawa, T. Kubo,
A. Fujino
P-25-015
Effects of escitalopram on the amygdala
dopamine release in emotional processing:
A specific effect in the methamphetamine-
sensitized rats
Makiko Yamada, Tokyo, Japan
H. Muraoka, M. Kawano, T. Kawano, T. Tsutsu-
mi, J. Miyagi, H. Oshibuchi, K. Inada, J. Ishi-
gooka
P-25-016
Identification of developmentally regulated
NMDA receptor antagonist phencyclidine-
responsive transcripts in the rat brain
Naoki Yamamoto, Tokyo, Japan
H. Takebayashi, A. Umino, T. Nishikawa
P-25-017
Effect of aripiprazole on subjective expe-
rience in antipsychotic-naïve first-episode
schizophrenia: First report
Yusuke Yamashita, Kawasaki, Kanagawa, Japan
S. Miyamoto, T. Tenjin, Y. Ninomiya, N. Miyake,
S. Ogino, H. Harada, Y. Kaneda, T. Sumiyoshi,
N. Yamaguchi
P-25-018
Interaction between paliperidone and car-
bamazepine
Norio Yasui-Furukori, Hirosaki, Japan
K. Kubo, M. Ishioka, S. Tsuchimine, Y. Inoue,
K. Nakamura
P-25-019
The differences of cognitive deficits in
chronic schizophrenia on long-term treat-
ment with typical and atypical antipsychotics
Mei Han, Wollongong, Australia
X.-F. Huang, X. Y. Zhang
P-25-020
Effect of pharmaceutical care by pharma-
cists on medication therapy in patients with
chronic schizophrenia
Yasuhiko Hashimoto, Kobe, Japan
M. Tensho
P-25-021
Blonanserin ameliorates phencyclidine-
induced impairment of visual recognition
memory (1): Involvement of dopamine-D
3
receptors
Hirotake Hida, Nagoya, Japan
Y. Matsumoto, A. Mouri, T. Seki, K. Mori, K. Yama-
da, N. Ozaki, T. Nabeshima, Y. Noda
P-25-022
Schizophrenic patients have a high preva-
lence of clinical and laboratory markers of
low plasminogen activators and/or plasmin
activity
Silvia Hoirisch-Clapauch, Rio de Janeiro, Brazil
A. E. Nardi
P-25-023
Sustained psychosis remission with warfa-
rin therapy
Silvia Hoirisch-Clapauch, Rio de Janeiro, Brazil
A. E. Nardi
P-25-024
Contributions of medial prefrontal cortex
and dorsomedial striatum to working mem-
ory capacity in rats
John Howland, Saskatoon, SK, Canada
D. Davies, Q. Greba, J. Selk, F. Syed
P-25-025
NS1738, a positive allosteric modulator of
Alpha7 nicotinic receptors, as adjunctive
treatment in schizophrenia. An experimen-
tal study
Kent Jardemark, Stockholm, Sweden
Å. Konradsson-Geuken, K. Feltmann, V. Ivanov,
B. Schilström, M. M. Marcus, T. Svensson
P-25-026
Association between FAT gene and schizo-
phrenia in the Korean population
Young-Eun Jung, Jeju, Republic of Korea
T.-Y. Jun
P-25-027
Disturbance of facial mimicry in schizophrenia
Kichang Kim, Chungcheongbuk, Republic of
Korea
G. Ju, J. W. Son, S. I. Lee, C. J. Shin, S. K. Kim,
H.-R. Ghim, J.-S. Eom, E. Moon, Y. O. Park,
Y.-U. Cheon
